Frequency of Low Levels of High Density Lipoprotein Cholesterol in Newly Diagnosed Patients of Acute Coronary Syndrome
DOI:
https://doi.org/10.70749/ijbr.v3i4.3017Keywords:
High density lipoprotein cholesterol, acute coronary syndrome, hypertensionAbstract
Background: One of the most significant causes of worldwide morbidity and mortality is acute coronary syndrome (ACS). One cardiovascular risk factor that is under-acknowledged, yet is significant, is dyslipidemia, specifically the low high-density lipoprotein cholesterol (HDL-C). Aim: To identify how often low HDL-C occurred in newly diagnosed ACS patients and how it is related to clinical risk factors. Methodology: It was a cross-sectional study that was carried out in the Faisalabad Institute of Cardiology between August 2021 and February 2022. The patient population of ACS was 125 with the age group 18-70. The amount of HDL-C was measured and analysed using SPSS. A critical p-value was set to be 0.05. Findings: There were 83.2% men and a mean age of 44.35 ± 9.69 years. 18.4% of patients had low HDL-C. Significant associations were seen with smoking (p=0.031) and hypertension (p=0.0009). Conclusion: HDL-C is a large and modifiable risk factor of ACS patients. Early intervention and screening are suggested.
Downloads
References
1. World Health Organization, Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019. Lancet. 2021;398(10307):1229–1239.
2. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction. Circulation. 2018;138(20):e618–e651.
https://doi.org/10.1161/cir.0000000000000617
3. Prabhakaran D, Jeemon P, Roy A, Pais P, Rangarajan S, Yusuf S, et al. Cardiovascular diseases in India and South Asia: epidemiology and prevention. Lancet. 2021;397(10278):134–146.
4. Zulfiqar N, Razzaq S, Satti S, Ahmed S, Khan M, Ali R, et al. Risk factors of cardiac diseases in Pakistan. J Community Health. 2020;45(5):1040–1046.
5. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. N Engl J Med. 2007;356(24):2412–2423.
https://doi.org/10.1001/jama.297.3.286
6. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. JAMA. 2017;318(12):1107–1108.
https://doi.org/10.1093/eurheartj/ehx144
7. Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014;371(25):2383–2393.
https://doi.org/10.1056/nejmoa1409065
8. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357(13):1301–1310.
https://doi.org/10.1056/nejmoa064278
9. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Circulation. 1989;79(1):8–15.
https://doi.org/10.1161/01.CIR.79.1.8
10. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases update. Lancet. 2020;396(10258):1223–1249.
11. Gupta R, Mohan I, Narula J, Rastogi P, Gupta VP, Khera A, et al. Trends in coronary heart disease epidemiology in India. Int J Cardiol. 2020;318:152–158.
https://doi.org/10.1016/j.aogh.2016.04.002
12. Misra A, Khurana L, Vikram NK, Goel A, Wasir JS, Pandey RM, et al. Metabolic syndrome in South Asians. Lancet. 2007;370(9599):1527–1538.
13. Maas AHEM, Appelman YEA, van der Graaf Y, Nathoe HM, Bots ML, Grobbee DE, et al. Gender differences in coronary heart disease. Eur Heart J. 2010;31(11):1327–1335.
https://doi.org/10.1007/s12471-010-0841-y
14. Mendelsohn ME, Karas RH, Clarkson TB, Appt SE, Bittner V, Shufelt C, et al. Estrogen and cardiovascular disease. N Engl J Med. 2005;352(17):1801–1811.
15. Rosenson RS, Brewer HB, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, et al. HDL structure and function. J Am Coll Cardiol. 2016;67(13):1664–1676.
16. Besler C, Heinrich K, Rohrer L, Doerries C, Riwanto M, Shih DM, et al. Mechanisms underlying HDL dysfunction. J Am Coll Cardiol. 2011;57(24):2436–2445.
17. Virdis A, Giannarelli C, Fritsch Neves M, Taddei S, Ghiadoni L, Salvetti A, et al. Endothelial dysfunction in hypertension. Hypertension. 2010;55(3):561–568.
18. Ambrose JA, Barua RS, Srivastava S, DeMarco T, Aikawa E, Libby P, et al. Smoking and cardiovascular disease. J Am Coll Cardiol. 2004;43(10):1731–1737.
https://doi.org/10.1016/j.jacc.2003.12.047
19. Craig WY, Palomaki GE, Haddow JE, Bostom AG, Wilson PW, Kannel WB, et al. Cigarette smoking and HDL cholesterol levels. Am J Cardiol. 1989;64(7):394–398.
20. Messner B, Bernhard D, Laufer G, Wick G, Fuchs D, Kronenberg F, et al. Smoking-induced inflammation and cardiovascular risk. Circ Res. 2014;115(1):1–9.
21. Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, et al. Major lipids and cardiovascular risk. Lancet. 2009;373(9671):1247–1257.
22. Khan B, Sawar S, Hassan M, Khan A, Rahman F, Noor N, et al. Frequency of lipid abnormalities in ACS patients. Pak Heart J. 2019;52(1):85–90.
23. Kontush A, Chapman MJ, Amarenco P, Goldstein LB, Kaste M, Lamotte M, et al. HDL functionality and cardiovascular risk. Atherosclerosis. 2015;243(1):150–160.
24. Navab M, Reddy ST, Van Lenten BJ, Fogelman AM, Berliner JA, Watson AD, et al. Dysfunctional HDL and atherosclerosis. J Am Coll Cardiol. 2011;58(12):1161–1172.
25. Kodama S, Tanaka S, Saito K, Shu M, Sone Y, Onitake F, et al. Effect of exercise on HDL cholesterol. Arch Intern Med. 2007;167(10):999–1008.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
